Who holds IQVIA's stock?
Get the latest Iqvia Holdings Inc (IQV) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
When did IQVIA go public?
IQVIA stock price target raised to $197 from $172 at SunTrust RH Jul. 27, 2020 at 7:05 a.m. ET by Tomi Kilgore Iqvia stock price target raised to $180 from $153 at Mizuho
Is IQVIA in the S&P 500?
Apr 24, 2022 · IQVIA's stock was trading at $125.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IQV stock has increased by 81.9% and is now trading at $228.16. View which stocks have been most impacted by COVID-19.
How does IQVIA's short interest stack up during the month of August?
Real time IQVIA Holdings, Inc. (IQV) stock price quote, stock graph, news & analysis.
Is Iqv stock a good buy?
Out of 13 analysts, 11 (84.62%) are recommending IQV as a Strong Buy, 1 (7.69%) are recommending IQV as a Buy, 1 (7.69%) are recommending IQV as a Hold, 0 (0%) are recommending IQV as a Sell, and 0 (0%) are recommending IQV as a Strong Sell. What is IQV's earnings growth forecast for 2022-2024?
Is Iqvia publicly traded?
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research....IQVIA.TypePublicTraded asNYSE: IQV S&P 500 componentIndustryContract Research Organization Pharmaceutical Service ConsultingFounded198210 more rows
What companies does Iqvia own?
IQVIA HOLDINGS INC. AIECO IT Solutions India Private Ltd. ALIMED Egeszsegugyi Szolgaltato Kft. APPATURE, INC.
How do I buy shares in IQVIA?
Yes, IQVIA Holdings Inc. shares can be bought in India by opening an international trading account with Groww.
Is IQVIA a pharmaceutical company?
IQVIA Pharma Inc. operates as a contract research company. The Company offers clinical development strategies, laboratory, site selection, patient recruitment, and research and development management consulting services to pharmaceutical, biotechnology, and healthcare industries.
How much does the CEO of IQVIA make?
As the Chairman of the Board, President, and Chief Executive Officer of IQVIA Inc, the total compensation of Ari Bousbib at IQVIA Inc is $22,139,800.Feb 14, 2022
What products does IQVIA sell?
Digital Planning Suite.Digital Site Suite.Digital Patient Suite.Digital Trial Management Suite.Clinical Data Analytics Suite.Patient Engagement.
Who bought Quintiles?
IMS Health Holdings Inc.IMS Health Holdings Inc. will buy Quintiles Transnational Holdings Inc. in an all-stock transaction for about $9 billion, bringing together two of the biggest providers of data and services for the pharmaceutical industry.May 3, 2016
Is IQVIA a buy right now?
17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IQVIA in the last twelve months. There are currently 1 hold rating and 16...
How has IQVIA's stock price been impacted by Coronavirus (COVID-19)?
IQVIA's stock was trading at $125.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organiza...
When is IQVIA's next earnings date?
IQVIA is scheduled to release its next quarterly earnings announcement on Thursday, April 28th 2022. View our earnings forecast for IQVIA .
How were IQVIA's earnings last quarter?
IQVIA Holdings Inc. (NYSE:IQV) issued its quarterly earnings data on Tuesday, February, 15th. The medical research company reported $2.42 EPS for t...
What guidance has IQVIA issued on next quarter's earnings?
IQVIA updated its FY 2022 earnings guidance on Tuesday, March, 1st. The company provided earnings per share guidance of $9.950-$10.250 for the peri...
What price target have analysts set for IQV?
17 Wall Street analysts have issued 1-year target prices for IQVIA's stock. Their forecasts range from $231.00 to $320.00. On average, they anticip...
Who are IQVIA's key executives?
IQVIA's management team includes the following people: Ari Bousbib , Chairman, President & Chief Executive Officer James Grant Berkshire , Senio...
What is Ari Bousbib's approval rating as IQVIA's CEO?
1,545 employees have rated IQVIA CEO Ari Bousbib on Glassdoor.com . Ari Bousbib has an approval rating of 84% among IQVIA's employees.
Who are some of IQVIA's key competitors?
Some companies that are related to IQVIA include ICON Public (ICLR) , Incyte (INCY) , Bitcoin Group (BTGGF) , Charles River Laboratories Intern...
What is IQVIA Holdings Inc?
Where is IQVIA headquartered?
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
What is IQVIA Holdings Inc?
and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina. Read More.
Where is IQVIA headquartered?
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Zen Score
and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Assets to liabilities
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IQV scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Cash flow
IQV's short-term liabilities ($5.24B) exceed... subscribe to Premium to read more.
